Explore the latest local coverage for FABHALTA^® (iptacopan)

Example information to submit for payer coverage requests

• Relevant medical records and clinical notes that support treatment  
• Appropriate clinical information from the Prescribing Information  
• Disease-specific criteria, which can include information such as the following:  
  • Confirm patient is 18 years or older  
  • Record of diagnosis by kidney biopsy, including MEST-C scoring if available  
  • Recent urine protein excretion (g/d) or UPCR (g/g) value  
  • Recent and prior assessment of patient renal function, including eGFR  
  • Indicator of inflammatory lesions and persistent hematuria  
  • Indicator of risk of rapid disease progression/kidney function loss  
  • List of all current and previous treatments for IgAN, including instances of intolerance to therapies, such as immunosuppressants, corticosteroids, or other branded therapies. Confirm that the patient has not achieved adequate results from current or prior therapy  
  • ACEi or ARB, or reason that the patient is not taking an ACEi/ARB or SGLT2i  
  • Documentation showing prior steroid therapy or reasons for non-eligibility for corticosteroids and other therapies  
• Treatment prescribed by or in consultation with a nephrologist